Many patients striving for weight loss turn to products marketed as “diet products” or labeled as healthy alternatives, but these options can often do more harm than good. AACE President Scott D.…
An NPR report explores how some patients are turning to the gray market to buy raw ingredients for obesity medications as a cheaper alternative to prescription drugs. AACE President Scott D. Isaacs,…
Advocating for Yourself
Living with the chronic disease of obesity isn't always easy. Learning how to advocate for yourself and for others can be empowering.
Please read on to learn…
According to the CDC, obesity affects roughly two in five Americans aged 60 and older, putting this population at greater risk for cardiovascular and metabolic diseases and a decreased quality of…
Found Health has become the latest telehealth company to offer a microdosing program with weight loss jabs, despite an absence of peer-reviewed scientific evidence that shows microdosing GLP-1RA…
AACE released a new consensus update to its Adiposity Based Chronic Disease (ABCD) Algorithm, enhancing the 2016 guidance with a stronger focus on complication centric, person centered care. Rather…
A new review published in Otolaryngology-Head and Neck Surgery reports that individuals with type 2 diabetes face a significantly elevated risk of hearing loss, particularly at higher…
According to new research, people with prediabetes who lower blood sugar to normal levels cut their heart disease risk in half. AACE President Scott D. Isaacs, MD, FACP, FACE, highlights that…
Following FDA approval of the first oral GLP-1 for obesity, AACE President Scott D. Isaacs, MD, FACP, FACE, called the Wegovy pill one of the most important developments in endocrinology in 2025,…
In a Medscape review on type 2 diabetes remission, AACE President Scott D. Isaacs, MD, FACP, FACE, emphasized that remission is not the same as reversal and highlighted growing evidence that…